About

Founded in late 2021, AI|ffinity s.r.o. is a spin-off from Masaryk University, supported by the Central European Institute of Technology (CEITEC) in Brno. We are dedicated to harnessing the power of NMR, AI, and Cheminformatics to create groundbreaking solutions for the pharmaceutical and biotechnology industries. Our offerings include quantifying protein-ligand binding affinity for hit discovery and lead optimization, characterizing protein-ligand interactions, and determining protein 3D structures.

Our comprehensive NMR-AI platform covers the entire target-to-lead process, and our efficient 4D NMR-AI technology finds its application in both drug design and protein engineering, such as nanobody design and biocatalysis. It is distributed to clients as a self-contained Docker image, which facilitates single-click installation.

Integrating drug design technology with NMR, our goal is to expedite the initial phases of drug discovery, enhance success rates, and cut costs by circumventing unneeded experiments. We operate from our headquarters at JIC INMEC in Brno-Medlánky, Czech Republic, and also have facilities at Prague's 6 Scott.Weber-Blox. Our long-term vision includes the establishment of an "NMR hub" in Brno and a "CADD hub" in Prague.